Recovery of dendritic cell counts and function in peripheral blood of cancer patients after chemotherapy

Cytokines, Cellular and Molecular Therapy

Volumn 7, Issue 1, 2002, Pages 15-24

  Markowicz, Sergiusz ^a   Walewski, Jan ^a   Zajda, Katarzyna ^a   Wiechno, Pawel J ^a   Skurzak, Henryk M ^a   Giermek, Jerzy ^a   Gajkowska, Agnieszka ^a   Krzakowski, Maciej ^a   Pienkowski, Tadeusz ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

CD4+ T cells; Chemotherapy; Dendritic cells; Lymphoma; Monocytes; Solid tumors

Indexed keywords

CD4 ANTIGEN; KEYHOLE LIMPET HEMOCYANIN; MONOCLONAL ANTIBODY CD3; CD3 ANTIGEN; HEMOCYANIN; INTERLEUKIN 2; KEYHOLE-LIMPET HEMOCYANIN; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CELL ASSAY; CELL COUNT; CELL FUNCTION; CELL POPULATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITE; FEMALE; HUMAN; HUMAN CELL; LYMPHOMA; MALE; PRIORITY JOURNAL; SOLID TUMOR; T LYMPHOCYTE; TREATMENT OUTCOME; BIOSYNTHESIS; BLOOD; CD4+ T LYMPHOCYTE; CELL DIVISION; CYTOLOGY; DENDRITIC CELL; IMMUNOPHENOTYPING; IMMUNOTHERAPY; METABOLISM; METHODOLOGY; MIDDLE AGED; NEOPLASM; TIME;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; DENDRITIC CELLS; FEMALE; HEMOCYANIN; HUMAN; IMMUNOPHENOTYPING; IMMUNOTHERAPY; INTERLEUKIN-2; LYMPHOMA; MALE; MIDDLE AGE; NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; HUMANS; MIDDLE AGED;

EID: 0036021843     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: 10.1080/13684730216404     Document Type: Article

References (45)

1. Dendritic cells and the control of immunity
2. Protein-specific helper T-lymphocyte formation initiated by dendritic cells
3. Activation and expansion of hapten- and protein-specific T helper cells from nonsensitized mice
4. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
5. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
6. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids
7. Accessory cell requirements for the mixed lymphocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells
8. Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro
9. The distinct surface of human blood dendritic cells, as observed after an improved isolation method
10. Dendritic cells: Unique leukocyte populations which control the primary immune response
11. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature
12. Dendritic cell ontogeny: A human dendritic cell lineage of myeloid origin
13. + peripheral blood dendritic cells are differentially regulated by cytokines
14. Reciprocal control of T helper cell and dendritic cell differentiation
15. Decreased antigen presentation by dendritic cells in patients with breast cancer
16. Circulating dendritic cells in early and advanced cancer patients: Diminished percent in the metastatic disease
17. The effect of immunosuppressive chemotherapy on immune function in patients with malignant disease
18. Inhibition of in vitro lymphocyte transformation during chemotherapy in man
19. Effects of chemotherapeutic agents on the immune response. I
20. Effects of chemotherapeutic agents on the immune response. II
21. Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients
22. + T cell lines from naive precursors
23. A method for directly determining the number of dendritic cells and for evaluation of their function in small amounts of human peripheral blood
24. + precursors
25. Human peripheral blood contains two distinct lineages of dendritic cells
26. Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: Implications for studies on antigen-presenting cell function and immunotherapy
27. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells
28. Flt-3 ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo
29. In vivo generation of human dendritic cell subsets by Flt3 ligand
30. Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors
31. + cells in mobilized peripheral blood of nonHodgkin's lymphoma patients
32. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages
33. + progenitors in human bone marrow
34. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells
35. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor α
36. + progenitors by tumor cells: Role of interleukin-6 and macrophage colony-stimulating factor
37. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate
38. + myeloid precursors
39. Type I (CD64) and type II (CD32) Fcγ receptor-mediated phagocytosis by human blood dendritic cells
40. Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation
41. + CTLs from naive precursors
42. + hematopoietic cells
43. + T-lymphocyte regeneration after intensive chemotherapy
44. + T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy
45. + cell transplantation